Aller au contenu principal
Profil bibliographique

Xianhua Meng

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

16Publications signalées
253Citations signalées
2Affiliations récentes

Les institutions déclarées

Les domaines associés

MicroRNA in disease regulationAcute Lymphoblastic Leukemia researchChronic Myeloid Leukemia TreatmentsReproductive System and PregnancyCircular RNAs in diseases

Les publications récentes

Accès ouvert 2025 review OpenAlex

Artificial intelligence (AI) in the diagnosis and prediction of adverse pregnancy outcomes for placenta accreta spectrum disorders (PAS): a systematic review and meta-analysis of diagnostic accuracy

Kai Chen, Mei Xue, Xianhua Meng, Guifang Li et autres

BACKGROUND: Precise prenatal diagnosis of Placenta accreta spectrum disorders (PAS) is challenging, and the diagnostic performance of conventional imaging modalities remains suboptimal. Artificial intelligence (AI) technologies have emerged as promising tools in assisting image analysis and improving diagnostic accuracy of PAS. Therefore, …

cn (code pays fourni par la source)

2 citations International Journal of Surgery
Accès ouvert 2023 review OpenAlex

Efficacy and safety of Gushen Antai Pills combined with dydrogesterone in the treatment of threatened miscarriage: a systematic review and meta-analysis

Kai Chen, Xiaoxia Liu, Xianhua Meng, Hui Li et autres

Background: Despite some progress has been made in the pathogenesis and treatment of threatened miscarriage (TM), conventional treatment remains suboptimal. Thus, complementary medicine gradually become a new treatment option for treating threatened miscarriage. Gushen Antai Pills (GAP), a classic prescription of Traditional …

cn (code pays fourni par la source)

5 citations Frontiers in Pharmacology
Accès ouvert 2022 report OpenAlex

Efficacy and safety of Gushen Antai Pills combined with dydrogesterone in the treatment of threatened miscarriage: A Systematic Review and Meta-Analysis

kai Chen, Xiaoxia Liu, Xianhua Meng, Hui Li et autres

Review question / Objective: This meta-analysis aimed to systematically evaluate the therapeutic effects of integrating Gushen Antai Pills and dydrogesterone in the treatment of threatened miscarriage. Condition being studied: This meta-analysis was conducted to evaluate the efficacy and safety of integrated Gushen …

cn (code pays fourni par la source)

0 citations
Accès ouvert 2021 review OpenAlex

The Clinical Efficacy and Safety of Enhanced Recovery After Surgery for Cesarean Section: A Systematic Review and Meta-Analysis of Randomized Controlled Trials and Observational Studies

Xianhua Meng, Kai Chen, Chenchen Yang, Hui Li et autres

Background: Enhanced recovery after surgery (ERAS) has been adopted in some maternity units and studied extensively in cesarean section (CS) in the last years, showing encouraging results in clinic practice. However, the present evidence assessing the effectiveness of ERAS for CS remains …

cn (code pays fourni par la source)

60 citations Frontiers in Medicine
Accès ouvert 2020 article OpenAlex

Efficacy and safety of nintedanib in Asian patients with systemic sclerosis-associated interstitial lung disease: Subgroup analysis of the SENSCIS trial

Arata Azuma, Digambar Behera, Melody P. Chung, Yasuhiro Kondoh et autres

BACKGROUND AND OBJECTIVE: In the SENSCIS trial in patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD), nintedanib reduced the rate of decline in forced vital capacity (FVC) (mL/year) over 52 weeks by 44% in comparison with placebo, with manageable adverse events in …

jp, us, in, cn, ch, de (code pays fourni par la source)

21 citations Respiratory Investigation
Accès ouvert 2020 article OpenAlex

Applying Serum Proteins and MicroRNA as Novel Biomarkers for Early-Stage Cervical Cancer Detection

Shengye Du, Yinghui Zhao, Changyu Lv, Meiling Wei et autres

Recently, we have been seeing emerging applications of non-invasive approaches using serum biomarkers including miRNA and proteins in detection of multiple cancers. Currently, majority of these methods only use solitary type of biomarkers, which often lead to non-satisfactory sensitivity and specificity in …

cn (code pays fourni par la source)

49 citations Scientific Reports
Accès ouvert 2018 article OpenAlex

An Observational Study of Chinese Adults with Relapsed/Refractory Philadelphia-Negative Acute Lymphoblastic Leukemia

Jun Ma, Ting Liu, Jie Jin, Jianda Hu et autres

AIM: Chinese adults with relapsed/refractory Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia (Ph- ALL) have poor outcomes. PATIENTS & METHODS: We conducted a nationwide, retrospective, observational study to assess outcomes in this patient population. RESULTS: Of the 270 enrolled patients, 31% of …

cn, us (code pays fourni par la source)

4 citations International Journal of Hematologic Oncology
Accès ouvert 2017 article OpenAlex

Regulatory roles of miRNA-758 and matrix extracellular phosphoglycoprotein in cervical cancer

Xianhua Meng, Yinghui Zhao, Jinyun Wang, Zheng Gao et autres

The present study aimed to examine the role and underlying mechanism of miRNA-758 (miR-758) expression in cancer tissues, blood and cervical exfoliated cells from patients with cervical cancer. A total of 49 patients with cervical cancer and 26 healthy people for cervical …

cn (code pays fourni par la source)

27 citations Experimental and Therapeutic Medicine
2016 article OpenAlex

Retrospective Study Evaluating Hematological Remission Rates and Survival in Chinese Adults with Relapsed or Refractory (r/r) Philadelphia Chromosome Negative (Ph-) B-Precursor Acute Lymphoblastic Leukemia (ALL)

Jun Ma, Ting Liu, Jie Jin, Jianda Hu et autres

Abstract Introduction: Outcomes are poor among Chinese adults with r/r ALL. Current recommendations in China for the treatment of adults with Ph- ALL include induction therapy with vincristine or vindesine, anthracyclines/anthraquinones, and corticosteroids; intensive consolidation therapy following complete remission (CR); and hematopoietic …

cn (code pays fourni par la source)

0 citations Blood

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.